Grastim 300mcg Injection

About

Grastim 300mcg Injection contains Filgrastim, a recombinant human granulocyte colony-stimulating factor (G-CSF). This medication works by stimulating the bone marrow to produce more neutrophils, a type of white blood cell crucial for fighting infections. It is primarily used to reduce the incidence and duration of neutropenia, a condition characterized by abnormally low levels of neutrophils, which can occur as a side effect of chemotherapy or bone marrow transplantation. By increasing neutrophil counts, Grastim helps to prevent serious bacterial infections in immunocompromised patients, thereby improving their recovery and overall clinical outcomes. It also plays a role in mobilizing peripheral blood stem cells for collection and subsequent transplantation.

Uses

• Reduce infection risk after chemotherapy.
• Mobilize peripheral blood stem cells for transplantation.
• Treat severe chronic neutropenia.
• Manage neutropenia in HIV patients receiving antiviral therapy.

Directions For Use

Administer subcutaneously or intravenously as directed by a healthcare professional. Do not shake the vial.

Benefits

• Reduces the risk of serious infections.
• Shortens the duration of chemotherapy-induced neutropenia.
• Enhances recovery of the immune system.
• Facilitates successful stem cell collection.
• Improves quality of life for neutropenic patients.
• Supports bone marrow function after transplantation.

Side Effects

• Bone pain
• Muscle pain
• Headache
• Nausea
• Fatigue
• Diarrhea
• Rash
• Injection site reactions
• Spleen enlargement
• Allergic reactions
• Thrombocytopenia
• Leukocytosis

Safety Measures

• Alcohol - No specific interaction known, but excessive alcohol can impair overall health and immune function.
• Pregnancy - Use only if clearly needed; potential risks to the fetus should be weighed against maternal benefit.
• Breastfeeding - Excretion into breast milk is unknown; caution advised, consider discontinuing breastfeeding or the drug.
• Liver - No specific dose adjustment needed, but monitor patients with severe hepatic impairment.
• Kidney - No specific dose adjustment needed, but monitor patients with severe renal impairment.
• Lung - Rare cases of acute respiratory distress syndrome (ARDS) reported; monitor for pulmonary symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.